These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8988766)

  • 1. Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
    Cormican MG; Johnson DM; Jones RN
    Diagn Microbiol Infect Dis; 1996 Jan; 24(1):59-60. PubMed ID: 8988766
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort.
    Linden PK; Pasculle AW; McDevitt D; Kramer DJ
    J Antimicrob Chemother; 1997 May; 39 Suppl A():145-51. PubMed ID: 9511079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns.
    Furlong WB; Rakowski TA
    Clin Infect Dis; 1997 Jul; 25(1):163-4. PubMed ID: 9243059
    [No Abstract]   [Full Text] [Related]  

  • 4. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium.
    Winston DJ; Emmanouilides C; Kroeber A; Hindler J; Bruckner DA; Territo MC; Busuttil RW
    Clin Infect Dis; 2000 May; 30(5):790-7. PubMed ID: 10817685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin.
    Summers M; Misenhimer GR; Antony SJ
    South Med J; 2001 Mar; 94(3):353-5. PubMed ID: 11284529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group.
    Moellering RC; Linden PK; Reinhardt J; Blumberg EA; Bompart F; Talbot GH
    J Antimicrob Chemother; 1999 Aug; 44(2):251-61. PubMed ID: 10473233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia.
    Chow JW; Donahedian SM; Zervos MJ
    Clin Infect Dis; 1997 Jan; 24(1):90-1. PubMed ID: 8994759
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents.
    Matsumura SO; Louie L; Louie M; Simor AE
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2776-9. PubMed ID: 10543762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
    Tan TY; Pitman I; Penrose-Stevens A; Simpson BA; Flanagan PG
    J Infect; 2000 Jul; 41(1):95-7. PubMed ID: 11041712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
    Tush GM; Huneycutt S; Phillips A; Ward JD
    Clin Infect Dis; 1998 Jun; 26(6):1460-1. PubMed ID: 9636880
    [No Abstract]   [Full Text] [Related]  

  • 12. Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report.
    Sahgal VS; Urban C; Mariano N; Weinbaum F; Turner J; Rahal JJ
    Microb Drug Resist; 1995; 1(3):245-7. PubMed ID: 9158782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination.
    Matsumura S; Simor AE
    Clin Infect Dis; 1998 Dec; 27(6):1554-6. PubMed ID: 9868693
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin.
    Linden PK; Moellering RC; Wood CA; Rehm SJ; Flaherty J; Bompart F; Talbot GH;
    Clin Infect Dis; 2001 Dec; 33(11):1816-23. PubMed ID: 11668430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro synergistic effect of retapamulin with erythromycin and quinupristin against Enterococcus faecalis.
    Park B; Min YH
    J Antibiot (Tokyo); 2020 Sep; 73(9):630-635. PubMed ID: 32346089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinupristin/dalfopristin: a therapeutic review.
    Allington DR; Rivey MP
    Clin Ther; 2001 Jan; 23(1):24-44. PubMed ID: 11219478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases.
    Dever LL; Smith SM; Dejesus D; Masurekar M; Patel D; Kaminski ZC; Johanson WG
    Microb Drug Resist; 1996; 2(4):407-13. PubMed ID: 9158811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance in enterococci isolated from Turkey flocks fed virginiamycin.
    Welton LA; Thal LA; Perri MB; Donabedian S; McMahon J; Chow JW; Zervos MJ
    Antimicrob Agents Chemother; 1998 Mar; 42(3):705-8. PubMed ID: 9517958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinupristin-dalfopristin and linezolid: evidence and opinion.
    Eliopoulos GM
    Clin Infect Dis; 2003 Feb; 36(4):473-81. PubMed ID: 12567306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.
    Lamb HM; Figgitt DP; Faulds D
    Drugs; 1999 Dec; 58(6):1061-97. PubMed ID: 10651391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.